Highlights Advicenne

Equities

ALDVI

FR0013296746

Market Closed - Euronext Paris Other stock markets 11:35:03 2024-05-16 am EDT			5-day change	1st Jan Change
1.934 ^EUR	-1.83%		+7.44%	-27.29%

Apr. 08	Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 25	Advicenne: ODD designation in cystinuria	CF

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 07	CI
Advicenne: share price hit after 2023 sales figures	Jan. 24	CF
Advicenne: launch of a capital increase	23-09-11	CF
Advicenne S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-10	CI
Advicenne: reduced losses for fiscal 2022	23-03-31	CF
Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Advicenne Announces the Launch of Sibnayal in Denmark	23-03-06	CI
Advicenne Completes European Commercial Coverage of Sibnayal(R) Through Its Agreement with Avanzanite Bioscience	23-02-28	CI
Advicenne and SPA Società Prodotti Antibiotici Announce an Exclusive Distribution Agreement for the Marketing of Sibnayal® in Italy, Spain and Portugal	23-02-14	CI
Advicenne Provides an Update on Its Commercial Partnerships in Europe and the Middle East	23-02-01	CI
Advicenne S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-20	CI
Advicenne Updates on Availability of Sibnayal to Patients and Caregivers in Great Britain	22-09-14	CI
Advicenne Announces Commercial Launch of Sibnayal in Great Britain	22-06-30	CI
France's Advicenne Taps Oman-based Distributor for Kidney Disease Drug	22-06-28	MT
Advicenne S.A. Signs an Exclusive Distribution Agreement with Taïba Healthcare	22-06-28	CI
Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Advicenne Announces the Release of Results of a Study Showing Improved Quality of Life in Patients Living With DRTa and Treated by ADV7103	22-03-30	CI
Advicenne Moves Listing To Euronext Growth Paris	22-03-28	MT
Advicenne Wins Shareholder Nod to Move Listing to Euronext Growth Paris	22-01-23	MT
Advicenne Signs Nordic Distribution Deal For Renal Disease Drug	22-01-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Advicenne

Equities

ALDVI

FR0013296746

Highlights

Filters